DarioHealth Corp.
General ticker "DRIO" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $710.5M (TTM average)
DarioHealth Corp. does not follow the US Stock Market performance with the rate: -6.1%.
Estimated limits based on current volatility of 2.7%: low 11.61$, high 12.26$
Factors to consider:
- Total employees count: 196 (-29.0%) as of 2024
- Top business risk factors: Operational and conduct risks, Capital adequacy, Geopolitical risks, Product reliance, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.33$, 24.62$]
- 2025-12-31 to 2026-12-31 estimated range: [6.94$, 20.61$]
Financial Metrics affecting the DRIO estimates:
- Negative: with PPE of -2.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -3.94 <= 0.04
- Negative: negative Industry operating cash flow (median)
- Positive: 42.53 < Shareholder equity ratio, % of 60.58 <= 64.17
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -4.41 < Investing cash flow per share per price, % of -0.91
- Positive: Inventory ratio change, % of -6.16 <= -0.76
Short-term DRIO quotes
Long-term DRIO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $27.66MM | $20.35MM | $27.04MM |
| Operating Expenses | $84.47MM | $76.54MM | $84.78MM |
| Operating Income | $-56.81MM | $-56.19MM | $-57.74MM |
| Non-Operating Income | $-5.38MM | $-3.17MM | $13.14MM |
| R&D Expense | $19.65MM | $20.25MM | $24.18MM |
| Income(Loss) | $-62.19MM | $-59.36MM | $-44.60MM |
| Taxes | $0.00MM | $0.06MM | $-1.85MM |
| Profit(Loss)* | $-62.19MM | $-59.43MM | $-42.75MM |
| Stockholders Equity | $80.00MM | $58.14MM | $72.02MM |
| Inventory | $7.96MM | $5.06MM | $4.75MM |
| Assets | $119.19MM | $96.39MM | $118.88MM |
| Operating Cash Flow | $-47.84MM | $-30.38MM | $-38.56MM |
| Capital expenditure | $0.57MM | $0.58MM | $0.14MM |
| Investing Cash Flow | $-0.57MM | $-0.55MM | $-8.93MM |
| Financing Cash Flow | $61.94MM | $18.25MM | $38.53MM |
| Earnings Per Share** | $-2.63 | $-2.09 | $-0.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.